Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Nature Communications|October 20, 2022
Force-triggered rapid microstructure growth on hydrogel surface for on-demand functionsQifeng Mu, Kunpeng Cui, Zhi Jian Wang, et al.
Frontiers in Oncology|March 17, 2017
Lenvatinib for Anaplastic Thyroid CancerMakoto Tahara, Naomi Kiyota, Tomoko Yamazaki, et al.
Scientific Reports|December 9, 2016
A proteolytic modification of AIM promotes its renal excretionTomoko Yamazaki, Ryoichi Sugisawa, Emiri Hiramoto, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 19, 2020
Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271Shinkichi Morita, Mai Mochizuki, Rie Shibuya-Takahashi, et al.
Surgical Oncology|September 6, 2020
Enhanced recovery after surgery program involving preoperative dexamethasone administration for head and neck surgery with free tissue transfer reconstruction: Single-center prospective observational studyTakayuki Imai, Koreyuki Kurosawa, Yukinori Asada, et al.
Future Oncology (London, England)|January 15, 2019
A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancerShunji Takahashi, Naomi Kiyota, Tomoko Yamazaki, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2021
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving ChemoradiationTomoya Yokota, Sadamoto Zenda, Ichiro Ota, et al.
Plos One|February 7, 2019
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinomaAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Cancer Science|April 8, 2026
Molecular and Cell Biological Characterization of Patient-Derived Head and Neck Squamous Carcinoma Cell LinesKazue Ito, Noriko Ishida, Shin Ito, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2016
A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinomaHironaga Satake, Makoto Tahara, Satoshi Mochizuki, et al.
Pageof 11